IRIS
MACCALLINI, Cristina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.563
EU - Europa 3.593
AS - Asia 2.987
SA - Sud America 302
AF - Africa 34
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 11.485
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.446
SG - Singapore 1.105
CN - Cina 948
IT - Italia 880
IE - Irlanda 485
TR - Turchia 437
UA - Ucraina 425
SE - Svezia 421
FR - Francia 303
GB - Regno Unito 298
BR - Brasile 269
IN - India 243
DE - Germania 218
PL - Polonia 147
FI - Finlandia 118
VN - Vietnam 115
CA - Canada 81
RU - Federazione Russa 75
AT - Austria 69
ES - Italia 42
CZ - Repubblica Ceca 25
MX - Messico 24
BE - Belgio 22
JP - Giappone 21
NL - Olanda 19
LT - Lituania 16
HK - Hong Kong 15
ZA - Sudafrica 15
BD - Bangladesh 14
KR - Corea 13
AR - Argentina 10
IQ - Iraq 9
ID - Indonesia 8
AE - Emirati Arabi Uniti 6
PK - Pakistan 6
TW - Taiwan 6
VE - Venezuela 6
EC - Ecuador 5
MY - Malesia 5
PT - Portogallo 5
AU - Australia 4
CO - Colombia 4
EG - Egitto 4
GR - Grecia 4
HR - Croazia 4
IL - Israele 4
PH - Filippine 4
SA - Arabia Saudita 4
CL - Cile 3
DZ - Algeria 3
IR - Iran 3
JO - Giordania 3
MA - Marocco 3
PE - Perù 3
SK - Slovacchia (Repubblica Slovacca) 3
TT - Trinidad e Tobago 3
YE - Yemen 3
AL - Albania 2
AZ - Azerbaigian 2
BG - Bulgaria 2
CH - Svizzera 2
CR - Costa Rica 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
JM - Giamaica 2
LB - Libano 2
PY - Paraguay 2
RS - Serbia 2
SN - Senegal 2
TN - Tunisia 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BB - Barbados 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
ET - Etiopia 1
EU - Europa 1
GD - Grenada 1
KE - Kenya 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
LV - Lettonia 1
MM - Myanmar 1
NO - Norvegia 1
NP - Nepal 1
PA - Panama 1
QA - Qatar 1
RO - Romania 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
ZW - Zimbabwe 1
Totale 11.485
Salva come PNG Salva come JPEG
Città #
Singapore 825
Chandler 605
Jacksonville 511
Dublin 477
Ashburn 331
Izmir 282
Beijing 237
Dearborn 233
Dallas 220
Chieti 211
Southend 198
Princeton 194
Nanjing 150
The Dalles 136
Los Angeles 120
Ann Arbor 119
Santa Clara 113
Kraków 108
Cambridge 103
Wilmington 96
New York 71
Nanchang 66
Altamura 62
Pescara 62
Vienna 56
Tongling 55
Munich 53
Buffalo 51
Boardman 47
Ho Chi Minh City 42
Bosa 40
Warsaw 35
Houston 34
Shenyang 34
São Paulo 34
Teramo 33
Woodbridge 32
Hebei 31
Helsinki 31
Jiaxing 30
Brooklyn 29
Kocaeli 28
Redondo Beach 28
Tianjin 28
Kunming 26
Jinan 25
Denver 24
Brno 23
Hefei 23
Rome 23
Brussels 22
Atlanta 21
Ottawa 21
Toronto 21
Washington 21
Changsha 20
Chennai 20
Fairfield 19
Ningbo 18
Tokyo 18
Hangzhou 17
Montreal 17
Stockholm 17
London 16
Hanoi 15
Milan 15
Turku 15
Nuremberg 14
Orem 13
Poplar 13
Bologna 12
Falls Church 12
Guangzhou 12
Hong Kong 12
Johannesburg 12
Norwalk 12
Dong Ket 11
Phoenix 11
Amsterdam 10
Chicago 10
Como 10
Rio de Janeiro 10
San Francisco 10
Seattle 10
Ankara 9
Augusta 9
Mexico City 9
Orange 9
Zhengzhou 9
Auburn Hills 8
Changchun 8
Moscow 8
Pune 8
Redwood City 8
Seoul 8
Bari 7
Biên Hòa 7
Manchester 7
Nogarole Vicentino 7
Curitiba 6
Totale 7.059
Salva come PNG Salva come JPEG
Nome #
Valutazione biologica e computazionale di inibitori della Ossido Nitrico Sintasi 228
Synthesis of 2-aryloxypropanoic acids analogues of clofibric acid and assignment of the absolute configuration by 1H NMR spectroscopy and DFT calculations 173
Discovery of N-{3-[(ethanimidoylamino)methyl]benzyl}-L-prolinamide dihydrochloride: A new potent and selective inhibitor of the inducible nitric oxide synthase as a promising agent for the therapy of malignant glioma 168
Synthesis and antibacterial evaluation of oxazolidin-2-ones structurally related to linezolid 166
Anticancer Activity of Stilbene-Based Derivatives 155
Titanium-Promoted Acylation of Sulfonamides to N-Acylsulfonamide PPAR Antagonists 152
Synthesis, biological activity, and docking studies of novel acetamidines as selective modulators of nitric oxide synthase 150
Synthesis and biological evaluation of potential Nitric Oxide Synthase inhibitors 148
Synthesis and structure-activity relationships of fibrate-based analogues inside PPARs 148
Valutazione biologica dei derivati dell'acido clofibrico come potenziali ligandi PPARs 147
Synthesis and Biological Evaluation of 2-Heteroarylthioalkanoic Acid Analogues of Clofibric Acid as Peroxisome Proliferator-Activated Receptor alfa Agonists 146
Amidine N-sostituite come potenziali inibitori delle Ossido Nitrico Sintasi 145
Determinazione della configurazione assoluta di acidi carbossilici a-sostituiti di interesse farmaceutico attraverso spettroscopia NMR 138
Recent developments of amidine-like compounds as selective NOS inhibitors 138
Antiglioma Activity of Aryl and Amido-Aryl Acetamidine Derivatives Targeting iNOS: Synthesis and Biological Evaluation 138
Synthesis of benzothiazolyl-thioalkanoic acids and pharmacological evaluation on PPARa 136
Novel Phenyldiazenyl Fibrate Analogues as PPAR α/γ/δ Pan-Agonists for the Amelioration of Metabolic Syndrome 136
Candida rugosa lipase-catalysed kinetic resolution of 2-substituted-aryloxyacetic esters with dimethylsulfoxide and isopropanol as additives 135
Asymmetric Synthesis of Arylpropionic Acids and Aryloxy Acids by Using Lactamides as Chiral Auxiliaries 135
Cytotoxic effect of a family of Peroxisome Proliferator-Activated Receptor antagonists in colorectal and pancreatic cancer cell lines 135
Discovery of new FXR agonists based on 6-ECDCA binding properties by virtual screening and molecular docking 135
Synthesis and biological evaluation of gemfibrozil chiral analogs as potential PPARa agonists 131
Hemopressin peptides as modulators of the endocannabinoid system and their potential applications as therapeutic tools 131
The Selective Acetamidine-Based iNOS Inhibitor CM544 Reduces Glioma Cell Proliferation by Enhancing PARP-1 Cleavage In Vitro 131
Enantiomeric separation of Gemfibrozil chiral analogues by capillary electrophoresis with heptakis(2,3,6-tri-O-methyl)-beta-cyclodextrin as chiral selector 130
Synthesis and biological characterization of 3-(imidazol-1-ylmethyl)piperidine sulfonamides as aromatase inhibitors 129
null 128
Druggability profile of stilbene-derived PPAR agonists: Determination of physicochemical properties and PAMPA study 128
PPARα agonists based on stilbene and its bioisosteres: Biological evaluation and docking studies 127
Syntesis and pharmacological evaluation of fibrates analogues as cardiovascular agents 126
Benzothiazole-based N-(phenylsulfonyl)amides as a novel familyof PPARa antagonists 126
Synthetic Strategies to Serine-Proline Chimeras: An Overview 125
Convergent Solution Phase and Solid Phase Synthesis for the Preparation of beta- Lactam antibiotic libraries. 124
Sintesi e valutazione biologica di analoghi eterociclici del gemfibrozil a potenziale attività cardiovascolare 124
Synthesis and antiplatelet activity of clofibric acid analogues 122
Synthesis, biological evaluation and docking studies of N-substituted acetamidines as selective inhibitors of inducible nitric oxide synthase 122
Indazole, Pyrazole, and Oxazole Derivatives Targeting Nitric Oxide Synthases and Carbonic Anhydrases 122
Synthesis and cytotoxic effects on pancreatic cancer cells of resveratrol analogs 122
Fibrate-derived N-(methylsulfonyl)amides with antagonistic properties on PPARa 120
Synthesis and biological evaluation of new acetamidines as selective inhibitors of Nitric Oxide Synthases 120
Synthesis of naphthyl-, quinolin- and anthracenyl analogues of clofibric acid as PPARα agonists 120
Selective inhibition of inducible Nitric Oxide Synthase by derivatives of acetamidine 117
Sulfonimide and Amide Derivatives as Novel PPARα Antagonists: Synthesis, Antiproliferative Activity, and Docking Studies 115
Discovery of gemfibrozil analogues that activate PPARa and enhance the expression of gene CPT1A involved in fatty acids catabolism 114
The excitation-contraction coupling on C2C12 skeletal muscle myotubes was modulated by NO-donor ester of gemfibrozil 112
Starting a new series of acetamidines as Nitric Oxide Sinthase inhibitors 111
Amidine-Based Compounds Affecting L-Arginine Metabolism 111
Fibrate-based N-acylsulphonamides targeting carbonic anhydrases: synthesis, biochemical evaluation, and docking studies 111
Multitarget PPARγ agonists as innovative modulators of the metabolic syndrome 111
Novel aminobenzyl-acetamidine derivative modulate the differential regulation of NOSs in LPS induced inflammatory response: Role of PI3K/Akt pathway 111
Dynamic kinetic resolution of α-bromoesters containing lactamides as chiral auxiliaries 110
Selective Acetamidine-Based Nitric Oxide Synthase Inhibitors: Synthesis, Docking, and Biological Studies 110
Selective Inhibition of iNOS by Benzyl- and Dibenzyl Derivatives of N-(3-Aminobenzyl)acetamidine. 109
Synthesis and biological evaluation of novel acetamidines as nitric oxide inhibitors 108
N-Substituted acetamidines and 2-methylimidazole derivatives as selective inhibitors of neuronal nitric oxide synthase 108
Sintesi di esteri del gemfibrozil donatori di ossido nitrico 108
Structural development studies of PPARs ligands based on tyrosine scaffold 107
Selective inhibition of iNOS by benzyl- and dibenzyl derivatives of N-(3-aminobenzyl)acetamidine on cellular line H2C9 105
Amidine-Based Bioactive Compounds for the Regulation of Arginine Metabolism 105
Targeting neuronal nitric oxide synthase as a valuable strategy for the therapy of neurological disorders 105
Synthesis of potential dual binding site acetylcholinesterase inhibitors through an efficient solid phase approach based on the Mitsunobu reaction 104
Analoghi eterociclici dell’acido clofibrico: sintesi, attività antiaggregante piastrinica e separazione in elettroforesi capillare 103
Synthesis, characterization and evaluation of gemfibrozil-stilbene hybrid as antioxidant agent 103
Dual-PPAR agonists based on stilbene scaffold: synthesis and biological evaluation 101
Synthetic methodologies for the preparation of arginine-proline derivatives 101
Synthesis, biological evaluation, and docking study of indole aryl sulfonamides as aromatase inhibitors 100
Effect of stilbene and chalcone scaffolds incorporation in clofibric acid on PPARα agonistic activity 99
Design, synthesis and biological activity of selective hCAs inhibitors based on 2-(benzylsulfinyl)benzoic acid scaffold 99
Synthesis and cytotoxicity evaluation of novel amide and sulfonimide PPARa antagonists 97
Platelet aggregation: synthesis and pharmacological evaluation of clofibric acid analogues 96
N-substituted acetamidines as nitric oxide synthase inhibitors 95
“Insight into diastereospecific solvolysis of peptidyl-b-lactams: combined kinetic and conformational studies” 95
Targeting iNOS As a Valuable Strategy for the Therapy of Glioma 94
Novel Phenyldiazenyl Fibrate Analogues as PPAR Agonists: Design, Synthesis and Pharmacological Evaluation 93
New amidine-benzenesulfonamides as iNOS inhibitors for the therapy of the triple negative breast cancer 92
In vitro protective effects of resveratrol and stilbene alkanoic derivatives on induced oxidative stress on c2c12 and mcf7 cells 92
Design, synthesis and biological evaluation of imidazole and triazole-based carbamates as novel aromatase inhibitors 92
Synthesis of novel benzothiazole amides: Evaluation of PPAR activity and anti-proliferative effects in paraganglioma, pancreatic and colorectal cancer cell lines 91
Benzothiazole Derivatives Endowed with Antiproliferative Activity in Paraganglioma and Pancreatic Cancer Cells: Structure-Activity Relationship Studies and Target Prediction Analysis 90
Capillary electrophoretic enantioseparation of gemfibrozil analogues by use of TM-b-cyclodextrin as chiral selector 90
Design, synthesis and biological evaluation of novel acetamidines as selective inducible nitric oxide synthase inhibitors 89
Sintesi di derivati eterociclici dell’acido clofibrico a potenziale attività antiaggregante piastrinica 89
Fibrate-Based Analogues as PPARs Agonists: Synthesis and Structure–Activity Relationships 88
Methods to Evaluate the Activity of Nitric Oxide Synthase 87
Synthesis, structure-activity relationships and molecular docking studies of phenyldiazenyl sulfonamides as aromatase inhibitors 87
Reversed-phase high-performance liquid chromatography method with fluorescence detection to screen nitric oxide synthases inhibitors. 86
QSAR, QSPR and QSRR in terms of 3-D-MoRSE descriptors for in silico screening of clofibric acid analogues 85
Acetamidine-Based iNOS Inhibitors as Molecular Tools to Counteract Inflammation in BV2 Microglial Cells 85
Design, synthesis and biological evaluation of aromatase inhibitors based on sulfonates and sulfonamides of resveratrol 85
Screening of NOS activity and selectivity of newly synthesized acetamidines using RP-HPLC 82
Insights into diastereospecific solvolysis of peptidyl-beta-lactams: combined kinetic and conformational studies 81
In vitro evaluation of a new selective iNOS inhibitor on normal rat astrocytes and C6 rat glioma cells 81
Geometric Isomerism of an Acetamidino Derivative Determined by NMR Investigations 80
A Novel Prodrug of a nNOS Inhibitor with Improved Pharmacokinetic Potential 78
Choline Chloride-Based DES as Solvents/Catalysts/Chemical Donors in Pharmaceutical Synthesis 78
Sintesi, relazioni struttura-attività e docking di nuovi inibitori delle Ossido Nitrico Sintasi 77
N-Acylsulfonylamides as a new class of PPARa antagonists 76
Preformulation studies and estimation of brain penetration for two alpidem analogues having anticonvulsant activity 72
Azobenzenesulfonamide Carbonic Anhydrase Inhibitors as New Weapons to Fight Helicobacter pylori: Synthesis, Bioactivity Evaluation, In Vivo Toxicity, and Computational Studies 71
Targeting Malassezia species for Novel Synthetic and Natural Antidandruff Agents 71
Totale 11.303
Salva come PNG Salva come JPEG
Categoria #
all - tutte 46.006
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.006
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021493 0 0 0 0 0 134 16 52 122 105 14 50
2021/2022661 13 13 22 105 70 18 24 49 97 30 71 149
2022/20231.712 124 243 127 169 162 345 88 129 213 21 56 35
2023/2024791 56 26 73 21 48 250 192 10 3 30 8 74
2024/20252.063 92 394 348 46 37 95 116 124 176 94 269 272
2025/20262.104 354 150 411 600 538 51 0 0 0 0 0 0
Totale 12.098